Status:
COMPLETED
The Effect of Nasal Carbon Dioxide (CO2) on Nasal Congestion in Subjects With Perennial Allergic Rhinitis
Lead Sponsor:
Capnia, Inc.
Conditions:
Perennial Allergic Rhinitis
Eligibility:
All Genders
19-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the effect of nasal CO2 on nasal congestion and other symptoms related to Perennial Allergic Rhinitis.
Detailed Description
A randomized study to evaluated the safety and effect of nasal carbon dioxide on nasal congestion using acoustic rhinometry in subjects with perennial allergic rhinitis. The acoustic rhinometry is an ...
Eligibility Criteria
Inclusion
- Have a history consistent with minimal 2 year history of perennial allergic rhinitis requiring pharmacotherapy.
- Positive skin test to perennial allergens (e.g. cats, dogs, house dust mite, etc.)
- Females of childbearing potential must commit to using an acceptable method of birth control and have a negative pregnancy test
Exclusion
- History of asthma (other than mild or intermittent)
- Clinically significant nasal disorders
- Acute or significant sinusitis or upper respiratory infection within 14 days of randomization
- Have an existing serious medical condition (such as severe emphysema, other respiratory diseases, heart disease, etc.) that precludes participation in the study
- Use of certain medication s prior to randomization and during study participation
- Participation in prior study with Nasal CO2
- Participation in another clinical study within 30 days of planned randomization date and for the duration of the study
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00638755
Start Date
February 1 2008
End Date
July 1 2008
Last Update
August 19 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Capnia Investigative Site
Omaha, Nebraska, United States, 68131